To further elucidate the effects of B cells on anti-tumor immunity in the context of MEK inhibition, we explored the effects of B cell depletion on gene expression profiling within the tumor microenvironment in MEK treated mice. The gene discussed is MAP2K7; the disease is neoplasm.